| Net Cash Provided by (Used in) Operating Activities |
$33,281,000 |
USD |
-117% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$4,970,000 |
USD |
-88% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$28,311,000 |
USD |
-211% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$79,403,000 |
USD |
-48% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$379,000 |
USD |
-48% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$8,325,000 |
USD |
441% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$4,113,000 |
USD |
237% |
Q3 2025 |
Q3 2025 |
| Current Income Tax Expense (Benefit) |
$94,000 |
USD |
840% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$1,103,855,000 |
USD |
11% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$3,809,000 |
USD |
376% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |